✦ LIBER ✦

Infectious morbidity after non myeloablative allogeneic hematopoietic stem cell transplantation (AHSCT)

✍ Scribed by A. Thiébaut; D. Antal; K. Bilger; M. Michallet; D. Fière

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-Myeloablative Allogeneic Hematopoiet

✍ Nonniekaye Shelburne; Margaret Bevans 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 132 KB

T cell (CD3+) chimerism after non-myeloa

✍ R. Sobecks; K. Theil; L. Rybicki; E. Kuczkowski; I. Warshawsky; R. Tubbs; M. Kal 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Chronic Kidney Disease after Myeloablati

✍ Sabina Kersting; Ronald J. Hené; Hein A. Koomans; Leo F. Verdonck 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 503 KB

Chronic Kidney Disease after Myeloablati

✍ Henk B. Kal; M. Loes van Kempen-Harteveld 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Non-myeloablative hematopoietic stem cel

✍ M. Maris; B.M. Sandmaier; D.G. Maloney; P.A. McSweeney; A. Woolfrey; T. Chauncey 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 71 KB

Procalcitonin in Pediatric Allogeneic He

✍ T.M. Watson; T.J. Fry; D.A. Jacobsohn; J. Sande; B. Yates; A. Stevenson 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB